Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Gastrointestinal 2Plasma cell 1Other neoplasm 1Other 1Lymphoid 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Pain, Intractable 1Neoplasms 1Mucositis 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Tirzepatide 9Methods 8Educational Status 8Exercise 6Early Intervention, Educational 6Interviews as Topic 5Counseling 5semaglutide 3Surveys and Questionnaires 3Standard of Care 3Resistance Training 3Radiotherapy 3Nutrition Assessment 3naldemedine 2Transcutaneous Electric Nerve Stimulation 2Specimen Handling 2Progestins 2Mouthwashes 2Mindfulness 2Megestrol Acetate 2Letrozole 2Health Promotion 2Exercise Test 2Echocardiography 2Drug Therapy 2Diet Therapy 2Bupropion 2mirabegron 1ma zi ren wan 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Morphine × Other × 1 year × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡